About 40% of at-risk patients with COPD did not receive maintenance therapy despite having frequent or severe exacerbations.
A large study presented at the 2026 ATS International Conference shows that patients treated for COPD or pneumonia experience ...
GSK’s RSV vaccine, Arexvy, receives expanded approval in Japan for adults aged 18–59 at increased risk: London, UK Tuesday, May 19, 2026, 12:00 Hrs [IST] GSK plc announced tha ...
Lupin received US FDA tentative approval for Revefenacin Inhalation Solution (175 mcg/3 mL), bioequivalent to Yupelri, ...
Among hospitalized adults with acute exacerbation of COPD, pegtarazimod improved oxygen utilization and inflammatory ...
The late-stage miss shakes analyst confidence in Regeneron’s clinical execution, according to BMO Capital Markets, also ...
A once-nightly oral pill helped control obstructive sleep apnea in a large, Phase III clinical trial presented at the 2026 ...
Exercise capacity and quality of life improved for children with chronic respiratory disease with pulmonary rehabilitation, ...
The Supplemental Oxygen Access Reform Act is bipartisan legislation that would expand access to oxygen services and equipment, helping people with COPD live life to the fullest.
Preliminary inspection found abnormality in screw-on connector at end of catheter used during heart operation on elderly man ...
cSt George's School of Health and Medical Sciences, City St George's University of London, London, UK dPublic Health Research Institute, St George's School of Health and Medical Sciences, City St ...
Hospital Authority says patient, who had history of chronic obstructive pulmonary disease and high cholesterol, died ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results